Wilex AG announced its plan to reduce the number of Supervisory Board members from six to five. Long-standing member Andreas Krebs will step down from the Supervisory Board at his own request for professional reasons after this year's Annual General Meeting. Both the Supervisory Board and the Executive Management Board accept his decision with regret and thank him for his active support of the company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.95 EUR | +1.03% | -1.68% | -21.93% |
Apr. 25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
Apr. 23 | Transcript : Heidelberg Pharma AG - Special Call |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.93% | 148M | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.51% | 21.83B | |
-11.02% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- HPHA Stock
- News Heidelberg Pharma AG
- Andreas Krebs to Step Down from the Supervisory Board of Wilex AG